Just spotted something interesting - a board member at Jazz Pharmaceuticals dropped nearly $10M buying their own company stock back in May. Seamus Mulligan picked up over 100k shares, which is the kind of move that usually catches traders' attention.

Jazz Pharma is that Ireland-based biotech company with a solid drug lineup - they've got treatments for narcolepsy, cancer, and epilepsy. Nothing groundbreaking in the recent numbers though, revenue's been pretty flat.

Here's the thing about insider buying: when someone like Seamus Mulligan puts their own money in, it usually signals they think the stock's undervalued or headed somewhere. Could be worth keeping an eye on. The stock was trading around $103 at the time, and analysts seem split on it. Not saying it's a guaranteed move, but insider confidence is always worth noting when you're scanning for opportunities.